Adenosquamous lung carcinoma
MONDO:0004973An aggressive carcinoma with a poor prognosis characterized by a presence of both malignant squamous cells and glandular cells.
Also known as: adenosquamous cell lung carcinoma, adenosquamous lung cancer, adenosquamous lung carcinoma, lung adenosquamous carcinoma
2813 clinical trials for this condition and its sub-types, 5 tagged with Adenosquamous lung carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New cocktail for tough lung cancer shows promise in small trial
Disease control OngoingThis phase 2 pilot trial tested adding the drug bevacizumab to standard chemotherapy and radiation for patients with stage III non-small cell lung cancer that cannot be removed by surgery. The study enrolled 29 newly diagnosed patients to see if the combination is safe and helps …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Radiation plus immunotherapy: a new hope for hard-to-treat lung cancer?
Disease control OngoingThis study is for people with advanced non-small cell lung cancer that does not have the PD-L1 marker, making it harder to treat with immunotherapy alone. The trial compares standard immunotherapy (with or without chemotherapy) to the same treatment plus radiation therapy. The go…
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New combo therapy aims to boost lung cancer fight
Disease control OngoingThis trial is testing a new way to give radiation therapy for people with stage II-III non-small cell lung cancer that cannot be removed with surgery. Instead of standard daily radiation for many weeks, patients receive a shorter, higher-dose course (hypofractionated radiation) a…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC